Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

USA - NASDAQ:CROX - US2270461096 - Common Stock

73.39 USD
-0.79 (-1.06%)
Last: 11/14/2025, 8:00:00 PM
73.5675 USD
+0.18 (+0.24%)
After Hours: 11/14/2025, 8:00:00 PM
Fundamental Rating

7

CROX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. CROX may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make CROX suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
CROX had a positive operating cash flow in the past year.
CROX had positive earnings in each of the past 5 years.
CROX had a positive operating cash flow in each of the past 5 years.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

CROX has a better Return On Assets (4.25%) than 64.58% of its industry peers.
Looking at the Return On Equity, with a value of 13.39%, CROX is in the better half of the industry, outperforming 70.83% of the companies in the same industry.
CROX has a Return On Invested Capital of 23.59%. This is amongst the best in the industry. CROX outperforms 89.58% of its industry peers.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 12.21%.
The last Return On Invested Capital (23.59%) for CROX is above the 3 year average (22.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROIC 23.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX has a better Profit Margin (4.48%) than 66.67% of its industry peers.
CROX's Profit Margin has improved in the last couple of years.
CROX has a better Operating Margin (23.11%) than 95.83% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX has a Gross Margin of 59.08%. This is in the better half of the industry: CROX outperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CROX has been reduced compared to 1 year ago.
Compared to 5 years ago, CROX has less shares outstanding
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.67 indicates that CROX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.67, CROX is doing good in the industry, outperforming 77.08% of the companies in the same industry.
The Debt to FCF ratio of CROX is 1.84, which is an excellent value as it means it would take CROX, only 1.84 years of fcf income to pay off all of its debts.
CROX's Debt to FCF ratio of 1.84 is amongst the best of the industry. CROX outperforms 85.42% of its industry peers.
A Debt/Equity ratio of 0.97 indicates that CROX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.97, CROX is doing worse than 72.92% of the companies in the same industry.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Altman-Z 3.67
ROIC/WACC2.12
WACC11.13%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.40 indicates that CROX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, CROX is doing worse than 77.08% of the companies in the same industry.
A Quick Ratio of 0.83 indicates that CROX may have some problems paying its short term obligations.
The Quick ratio of CROX (0.83) is worse than 64.58% of its industry peers.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.83
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for CROX have decreased by -4.09% in the last year.
CROX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.64% yearly.
The Revenue has been growing slightly by 0.01% in the past year.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%

3.2 Future

Based on estimates for the next years, CROX will show a small growth in Earnings Per Share. The EPS will grow by 2.84% on average per year.
The Revenue is expected to grow by 2.29% on average over the next years.
EPS Next Y-8.89%
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%
EPS Next 5Y2.84%
Revenue Next Year-1.88%
Revenue Next 2Y-1.1%
Revenue Next 3Y-1.32%
Revenue Next 5Y2.29%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.79, the valuation of CROX can be described as very cheap.
Based on the Price/Earnings ratio, CROX is valued cheaper than 95.83% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.89, CROX is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.04, the valuation of CROX can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 97.92% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.59. CROX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.79
Fwd PE 6.04
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

89.58% of the companies in the same industry are more expensive than CROX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CROX is valued cheaper than 93.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.6
EV/EBITDA 5.13
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The excellent profitability rating of CROX may justify a higher PE ratio.
CROX's earnings are expected to decrease with -2.79% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.11
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (11/14/2025, 8:00:00 PM)

After market: 73.5675 +0.18 (+0.24%)

73.39

-0.79 (-1.06%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners103.9%
Inst Owner Change-0.3%
Ins Owners2.6%
Ins Owner Change1.77%
Market Cap4.01B
Revenue(TTM)4.07B
Net Income(TTM)182.55M
Analysts73.64
Price Target89.54 (22.01%)
Short Float %13.06%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.3%
Min EPS beat(2)3.5%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)13.09%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)14.51%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)14.77%
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.48%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.48%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)9
Avg Revenue beat(16)0.56%
PT rev (1m)-0.09%
PT rev (3m)-29.28%
EPS NQ rev (1m)5.04%
EPS NQ rev (3m)-19.65%
EPS NY rev (1m)2.95%
EPS NY rev (3m)-6.88%
Revenue NQ rev (1m)-1.32%
Revenue NQ rev (3m)-7.43%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)-3.46%
Valuation
Industry RankSector Rank
PE 5.79
Fwd PE 6.04
P/S 0.98
P/FCF 5.6
P/OCF 5.14
P/B 2.94
P/tB N/A
EV/EBITDA 5.13
EPS(TTM)12.67
EY17.26%
EPS(NY)12.15
Fwd EY16.56%
FCF(TTM)13.11
FCFY17.87%
OCF(TTM)14.28
OCFY19.45%
SpS74.57
BVpS24.96
TBVpS-6.81
PEG (NY)N/A
PEG (5Y)0.11
Graham Number84.35
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROCE 26.08%
ROIC 23.59%
ROICexc 24.64%
ROICexgc 49.52%
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
FCFM 17.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Debt/EBITDA 1.3
Cap/Depr 83.38%
Cap/Sales 1.56%
Interest Coverage 11.87
Cash Conversion 76.65%
Profit Quality 392.36%
Current Ratio 1.4
Quick Ratio 0.83
Altman-Z 3.67
F-Score6
WACC11.13%
ROIC/WACC2.12
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
EPS Next Y-8.89%
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%
EPS Next 5Y2.84%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%
Revenue Next Year-1.88%
Revenue Next 2Y-1.1%
Revenue Next 3Y-1.32%
Revenue Next 5Y2.29%
EBIT growth 1Y-11.62%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-9.8%
EBIT Next 3Y-6.47%
EBIT Next 5Y3.43%
FCF growth 1Y-14.34%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-16.78%
OCF growth 3Y20.5%
OCF growth 5Y61.62%

CROCS INC / CROX FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CROX.


What is the valuation status for CROX stock?

ChartMill assigns a valuation rating of 8 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


What is the profitability of CROX stock?

CROCS INC (CROX) has a profitability rating of 9 / 10.


What are the PE and PB ratios of CROCS INC (CROX) stock?

The Price/Earnings (PE) ratio for CROCS INC (CROX) is 5.79 and the Price/Book (PB) ratio is 2.94.


Can you provide the financial health for CROX stock?

The financial health rating of CROCS INC (CROX) is 7 / 10.